---
title: "SMOC: Net profit of 18.1674 million yuan in the first half of 2025, year-on-year growth not applicable"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/254999716.md"
description: "SMOC announced that its operating income in the first half of 2025 was 196 million yuan, a year-on-year increase of 10.69%. The net profit was 18.1674 million yuan, compared to a loss of 9.1436 million yuan in the same period last year"
datetime: "2025-08-28T11:56:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/254999716.md)
  - [en](https://longbridge.com/en/news/254999716.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/254999716.md)
---

# SMOC: Net profit of 18.1674 million yuan in the first half of 2025, year-on-year growth not applicable

SMOC announced that its operating revenue in the first half of 2025 was 196 million yuan, a year-on-year increase of 10.69%. The net profit was 18.1674 million yuan, compared to a loss of 9.1436 million yuan in the same period last year

### Related Stocks

- [688265.CN](https://longbridge.com/en/quote/688265.CN.md)

## Related News & Research

- [Are There Really 'No Bad Ideas' When It Comes To 'Saving Or Democracy'?](https://longbridge.com/en/news/286701120.md)
- [Luminar Media Group changes name to Fortun Holdings](https://longbridge.com/en/news/287226546.md)
- [China's top flash-memory chipmaker YMTC begins pre-IPO coaching talks with investment bank](https://longbridge.com/en/news/286879811.md)
- [Malaysia’s IC firm SkyeChip jumps in IPO debut](https://longbridge.com/en/news/287034420.md)
- [China's Bio-Thera Gets US Nod for Golimumab Biosimilar](https://longbridge.com/en/news/286880573.md)